메뉴 건너뛰기




Volumn 2, Issue 6, 2007, Pages 1100-1103

HMG-CoA reductase inhibitors and renal function

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN; PYRROLE DERIVATIVE;

EID: 38449083527     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04060907     Document Type: Editorial
Times cited : (13)

References (40)
  • 1
    • 0027280249 scopus 로고
    • LDL stimulates mesangial fibronectin production and chemoattractant expression
    • Rovin BH, Tan LC: LDL stimulates mesangial fibronectin production and chemoattractant expression. Kidney Int 43: 218-225, 1993
    • (1993) Kidney Int , vol.43 , pp. 218-225
    • Rovin, B.H.1    Tan, L.C.2
  • 2
    • 27744446645 scopus 로고    scopus 로고
    • Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/ AKT-signaling pathway
    • Bussolati B, Deregibus MC, Fonsato V, Doublier S, Spatola T, Procida S, Di Carlo F, Camussi G: Statins prevent oxidized LDL-induced injury of glomerular podocytes by activating the phosphatidylinositol 3-kinase/ AKT-signaling pathway. J Am Soc Nephrol 16: 1936-1947, 2005
    • (2005) J Am Soc Nephrol , vol.16 , pp. 1936-1947
    • Bussolati, B.1    Deregibus, M.C.2    Fonsato, V.3    Doublier, S.4    Spatola, T.5    Procida, S.6    Di Carlo, F.7    Camussi, G.8
  • 3
    • 0035137324 scopus 로고    scopus 로고
    • Transcription factor-kB (NF-kB) and renal disease
    • Guijarro C, Egido J: Transcription factor-kB (NF-kB) and renal disease. Kidney Int 59: 415-424, 2001
    • (2001) Kidney Int , vol.59 , pp. 415-424
    • Guijarro, C.1    Egido, J.2
  • 4
    • 11844270511 scopus 로고    scopus 로고
    • Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases
    • Kuldo JM, Ogawara KI, Werner N, Asgeirsdottir SA, Kamps JA, Kok RJ, Molema G: Molecular pathways of endothelial cell activation for (targeted) pharmacological intervention of chronic inflammatory diseases. Curr Vasc Pharmacol 3: 11-39, 2005
    • (2005) Curr Vasc Pharmacol , vol.3 , pp. 11-39
    • Kuldo, J.M.1    Ogawara, K.I.2    Werner, N.3    Asgeirsdottir, S.A.4    Kamps, J.A.5    Kok, R.J.6    Molema, G.7
  • 6
    • 26444478235 scopus 로고    scopus 로고
    • Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction
    • Vieira JM Jr. Mantovani E, Rodrigues LT, Delle H, Noronha IL, Fujihara CK, Zatz R: Simvastatin attenuates renal inflammation, tubular transdifferentiation and interstitial fibrosis in rats with unilateral ureteral obstruction. Nephrol Dial Transplant 20: 1582-1591, 2005
    • (2005) Nephrol Dial Transplant , vol.20 , pp. 1582-1591
    • Vieira Jr., J.M.1    Mantovani, E.2    Rodrigues, L.T.3    Delle, H.4    Noronha, I.L.5    Fujihara, C.K.6    Zatz, R.7
  • 7
    • 0031883707 scopus 로고    scopus 로고
    • Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats
    • Park Y-S, Guijarro C, Kim Y, Massy ZA, Kasiske BL, Keane WF, O'Donnell MP: Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats. Am J Kidney Dis 31: 190-194, 1998
    • (1998) Am J Kidney Dis , vol.31 , pp. 190-194
    • Park, Y.-S.1    Guijarro, C.2    Kim, Y.3    Massy, Z.A.4    Kasiske, B.L.5    Keane, W.F.6    O'Donnell, M.P.7
  • 8
    • 0042376168 scopus 로고    scopus 로고
    • Mason JC: Statins and their role in vascular protection. Clin Sci (Lond) 105: 251-266, 2003 9 Crisby M: Modulation of the inflammatory process by statins. Drugs Today (Barc) 39: 137-143, 2003
    • Mason JC: Statins and their role in vascular protection. Clin Sci (Lond) 105: 251-266, 2003 9 Crisby M: Modulation of the inflammatory process by statins. Drugs Today (Barc) 39: 137-143, 2003
  • 9
    • 0141857806 scopus 로고    scopus 로고
    • Noncholesterol-lowering effects of statins
    • Pierre-Paul D, Gahtan V: Noncholesterol-lowering effects of statins. Vasc Endovascular Surg 37: 301-313, 2003
    • (2003) Vasc Endovascular Surg , vol.37 , pp. 301-313
    • Pierre-Paul, D.1    Gahtan, V.2
  • 10
    • 0034685031 scopus 로고    scopus 로고
    • Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: Effects of oxidation and modulation by lovastatin
    • Massy ZA, Kim Y, Guijarro C, Kasiske BL, Keane WF, O'Donnell MP: Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin. Biochem Biophys Res Commun 267: 536-540, 2000
    • (2000) Biochem Biophys Res Commun , vol.267 , pp. 536-540
    • Massy, Z.A.1    Kim, Y.2    Guijarro, C.3    Kasiske, B.L.4    Keane, W.F.5    O'Donnell, M.P.6
  • 11
    • 0029147229 scopus 로고
    • Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatin
    • Kim SY, Guijarro C, O'Donnell MP, Kasiske BL, Kim Y, Keane WF: Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatin. Kidney Int 48: 363-371, 1995
    • (1995) Kidney Int , vol.48 , pp. 363-371
    • Kim, S.Y.1    Guijarro, C.2    O'Donnell, M.P.3    Kasiske, B.L.4    Kim, Y.5    Keane, W.F.6
  • 12
    • 0036150077 scopus 로고    scopus 로고
    • Pravastatin suppress superoxide and fibronectin production of glomerular mesangial cells induced by oxidized-LDL and high glucose
    • Chen HC, Guh JY, Shin SJ, Lai YH: Pravastatin suppress superoxide and fibronectin production of glomerular mesangial cells induced by oxidized-LDL and high glucose. Atherosclerosis 160: 141-146, 2002
    • (2002) Atherosclerosis , vol.160 , pp. 141-146
    • Chen, H.C.1    Guh, J.Y.2    Shin, S.J.3    Lai, Y.H.4
  • 15
    • 0036445650 scopus 로고    scopus 로고
    • Modulation of inflammatory mediators and PPARgamma and NfkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro
    • Zelvyte I, Dominaitiene R, Crisby M, Janciauskiene S: Modulation of inflammatory mediators and PPARgamma and NfkappaB expression by pravastatin in response to lipoproteins in human monocytes in vitro. Pharmacol Res 45: 147-154, 2002
    • (2002) Pharmacol Res , vol.45 , pp. 147-154
    • Zelvyte, I.1    Dominaitiene, R.2    Crisby, M.3    Janciauskiene, S.4
  • 16
    • 0030820468 scopus 로고    scopus 로고
    • Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway
    • Vrtovsnik F, Couette S, Prie D, Lallemand D, Friedlander G: Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway. Kidney Int 52: 1016-1027, 1997
    • (1997) Kidney Int , vol.52 , pp. 1016-1027
    • Vrtovsnik, F.1    Couette, S.2    Prie, D.3    Lallemand, D.4    Friedlander, G.5
  • 17
    • 3042647296 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: A potential mechanism of statin-mediated vasculoprotection
    • Vamvakopoulos JE, Green C: HMG-CoA reductase inhibition aborts functional differentiation and triggers apoptosis in cultured primary human monocytes: A potential mechanism of statin-mediated vasculoprotection. BMC Cardiovasc Disord 3: 6, 2003
    • (2003) BMC Cardiovasc Disord , vol.3 , pp. 6
    • Vamvakopoulos, J.E.1    Green, C.2
  • 18
    • 0035723275 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: Involvement of Rho GTPase-dependent mechanism
    • Yoshida M, Sawada T, Ishii H, Gerszten RE, Rosenzweig A, Gimbrone MA Jr, Yasukochi Y, Numano F: HMG-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro: Involvement of Rho GTPase-dependent mechanism. Arterioscler Thromb Vasc Biol 21: 1165-1171, 2001
    • (2001) Arterioscler Thromb Vasc Biol , vol.21 , pp. 1165-1171
    • Yoshida, M.1    Sawada, T.2    Ishii, H.3    Gerszten, R.E.4    Rosenzweig, A.5    Gimbrone Jr, M.A.6    Yasukochi, Y.7    Numano, F.8
  • 20
    • 0034844264 scopus 로고    scopus 로고
    • Atorvastatin improves endothelial function in renal-transplant recipients
    • Asberg A, Hartmann A, Fjeldsa E, Holdaas H: Atorvastatin improves endothelial function in renal-transplant recipients. Nephrol Dial Transplant 16: 1920-1924, 2001
    • (2001) Nephrol Dial Transplant , vol.16 , pp. 1920-1924
    • Asberg, A.1    Hartmann, A.2    Fjeldsa, E.3    Holdaas, H.4
  • 21
    • 0032584177 scopus 로고    scopus 로고
    • Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors
    • Laufs U, La Fata V, Plutzky J, Liao JK: Upregulation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors. Circulation 97: 1129-1135, 1998
    • (1998) Circulation , vol.97 , pp. 1129-1135
    • Laufs, U.1    La Fata, V.2    Plutzky, J.3    Liao, J.K.4
  • 22
    • 0346736491 scopus 로고    scopus 로고
    • Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
    • Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C, Lamas S: Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101: 2711-2719, 1998
    • (1998) J Clin Invest , vol.101 , pp. 2711-2719
    • Hernandez-Perera, O.1    Perez-Sala, D.2    Navarro-Antolin, J.3    Sanchez-Pascuala, R.4    Hernandez, G.5    Diaz, C.6    Lamas, S.7
  • 23
    • 46449134065 scopus 로고    scopus 로고
    • Park JK, Muller DN, Mervaala EM, Dechend R, Fiebeler A, Schmidt F, Bieringer M, Schafer O, Lindschau C, Schneider W, Ganten D, Luft FC, Haller H: Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. Kidney Int 58: 1420-1430, 2000 25 Zhou M-S, Jaimes EA, Raij L: Atorvastatin prevents end-organ injury in salt-sensitive hypertension: Role of eNOS and oxidant stress. Hypertension 44: 186-190, 2004
    • Park JK, Muller DN, Mervaala EM, Dechend R, Fiebeler A, Schmidt F, Bieringer M, Schafer O, Lindschau C, Schneider W, Ganten D, Luft FC, Haller H: Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects. Kidney Int 58: 1420-1430, 2000 25 Zhou M-S, Jaimes EA, Raij L: Atorvastatin prevents end-organ injury in salt-sensitive hypertension: Role of eNOS and oxidant stress. Hypertension 44: 186-190, 2004
  • 24
    • 27144432809 scopus 로고    scopus 로고
    • Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD
    • Preston E, Ellis MR, Kulinskaya E, Davies AH, Brown EA: Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Am J Kidney Dis 46: 856-862, 2005
    • (2005) Am J Kidney Dis , vol.46 , pp. 856-862
    • Preston, E.1    Ellis, M.R.2    Kulinskaya, E.3    Davies, A.H.4    Brown, E.A.5
  • 28
    • 0029166463 scopus 로고
    • Effects of hypertension and dyslipidemia on the decline in renal function
    • Manttari M, Tiula E, Alikoski T, Manninen V: Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 26: 670-675, 1995
    • (1995) Hypertension , vol.26 , pp. 670-675
    • Manttari, M.1    Tiula, E.2    Alikoski, T.3    Manninen, V.4
  • 30
    • 1342344698 scopus 로고    scopus 로고
    • Cellular lipid metabolism and the role of lipids in progressive renal disease
    • Abrass CK: Cellular lipid metabolism and the role of lipids in progressive renal disease. Am J Nephrol 24: 46-53, 2004
    • (2004) Am J Nephrol , vol.24 , pp. 46-53
    • Abrass, C.K.1
  • 31
    • 0035166933 scopus 로고    scopus 로고
    • Fried LF, Orchard TJ, Kasiske BL; for the Lipids and Renal Disease Progression Meta-Analysis Study Group: Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 59: 260-269, 2001
    • Fried LF, Orchard TJ, Kasiske BL; for the Lipids and Renal Disease Progression Meta-Analysis Study Group: Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 59: 260-269, 2001
  • 32
    • 85190678243 scopus 로고    scopus 로고
    • Tonelli M, Moye L, Sacks FM, Cole T, Curhan GC; for the Cholesterol and Recurrent Events (CARE) Trial Investigators: Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol 14: 1605-1613, 2003
    • Tonelli M, Moye L, Sacks FM, Cole T, Curhan GC; for the Cholesterol and Recurrent Events (CARE) Trial Investigators: Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol 14: 1605-1613, 2003
  • 34
    • 27144534466 scopus 로고    scopus 로고
    • Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease
    • Verma A, Ranganna KM, Reddy RS, Verma M, Gordon NF: Effect of rosuvastatin on C-reactive protein and renal function in patients with chronic kidney disease. Am J Cardiol 96: 1290-1292, 2005
    • (2005) Am J Cardiol , vol.96 , pp. 1290-1292
    • Verma, A.1    Ranganna, K.M.2    Reddy, R.S.3    Verma, M.4    Gordon, N.F.5
  • 35
    • 0036271883 scopus 로고    scopus 로고
    • Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients
    • Chang JW, Yang WS, Min WK, Lee SK, Park JS, Kim SB: Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. Am J Kidney Dis 39: 1213-1217, 2002
    • (2002) Am J Kidney Dis , vol.39 , pp. 1213-1217
    • Chang, J.W.1    Yang, W.S.2    Min, W.K.3    Lee, S.K.4    Park, J.S.5    Kim, S.B.6
  • 36
    • 0037373832 scopus 로고    scopus 로고
    • A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease
    • Bianchi S, Bigazzi R, Caiazza A, Campese VM: A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. Am J Kidney Dis 41: 565-570, 2003
    • (2003) Am J Kidney Dis , vol.41 , pp. 565-570
    • Bianchi, S.1    Bigazzi, R.2    Caiazza, A.3    Campese, V.M.4
  • 37
    • 1542298565 scopus 로고    scopus 로고
    • The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease: A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study
    • Athyros VG, Mikhailidis DP, Papageorgiou AA, Symeonidis AN, Pehlivanidis AN, Bouloukos VI, Elisaf M: The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease: A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. J Clin Pathol 57: 728-734, 2004
    • (2004) J Clin Pathol , vol.57 , pp. 728-734
    • Athyros, V.G.1    Mikhailidis, D.P.2    Papageorgiou, A.A.3    Symeonidis, A.N.4    Pehlivanidis, A.N.5    Bouloukos, V.I.6    Elisaf, M.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.